ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,320Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 780

$788K Total Retail Price of All Prescriptions

Rank: 129 out of 780

376 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 14,627 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
LEVOTHYROXINE SODIUM 681 642 1 5
HYDROCODONE-ACETAMINOPHEN 654 598 S3 2 1
FUROSEMIDE 593 572 3 7
OMEPRAZOLE 553 521 4 3
LISINOPRIL 400 374 5 6
POTASSIUM CHLORIDE 395 345 6 11
SIMVASTATIN 352 311 7 2
METOPROLOL TARTRATE 263 233 8 19
AMLODIPINE BESYLATE 262 252 9 4
TRAMADOL HCL 255 208 10 15
DONEPEZIL HCL 242 242 11 31
CITALOPRAM HBR 227 224 12 23
METFORMIN HCL 227 202 12 8
POLYETHYLENE GLYCOL 3350 223 197 14 79
NAMENDA 218 214 15 46
TRAZODONE HCL 217 182 16 35
WARFARIN SODIUM 204 204 17 24
CIPROFLOXACIN HCL 194 164 18 49
TAMSULOSIN HCL 175 161 19 36
CYMBALTA 174 142 20 51
GABAPENTIN 167 129 21 13
DIVALPROEX SODIUM 162 162 22 119
QUETIAPINE FUMARATE 161 160 23 81
HYDROCHLOROTHIAZIDE 158 142 24 10
ALBUTEROL SULFATE 153 153 25 163
GLIMEPIRIDE 153 135 25 30
ATENOLOL 151 143 27 21
ESCITALOPRAM OXALATE 150 118 28 61
SERTRALINE HCL 148 103 29 27
NEXIUM 144 90 30 22
MIRTAZAPINE 143 129 31 58
PAROXETINE HCL 141 136 32 69
LOSARTAN POTASSIUM 136 134 33 18
ISOSORBIDE MONONITRATE ER 129 124 34 60
PLAVIX 128 119 35 45
DIGOXIN 124 124 36 56
CLONIDINE HCL 119 117 37 28
ALLOPURINOL 108 95 38 29
CLOPIDOGREL 108 98 38 34
PANTOPRAZOLE SODIUM 105 105 40 25
METOPROLOL SUCCINATE 104 75 41 20
ZOLPIDEM TARTRATE 101 95 42 17
HUMULIN 70-30 100 83 43 106
FAMOTIDINE 98 86 44 86
ATORVASTATIN CALCIUM 97 94 45 12
KLOR-CON M20 97 97 45 57
IBUPROFEN 97 69 45 93
DOXYCYCLINE HYCLATE 93 87 48 103
FLUOXETINE HCL 91 68 49 65
OXYBUTYNIN CHLORIDE ER 83 83 50 169
OXYBUTYNIN CHLORIDE 78 78 51 148
SYNTHROID 77 44 52 77
PRAVASTATIN SODIUM 77 75 52 9
ROPINIROLE HCL 75 45 54 87
DIOVAN 75 68 54 55
VESICARE 75 75 54 186
MELOXICAM 74 69 57 16
TRIAMTERENE-HCTZ 74 67 57 37
RISPERIDONE 73 61 59 98
SPIRONOLACTONE 72 71 60 53
CARVEDILOL 70 70 61 14
SEROQUEL 69 68 62 172
BUSPIRONE HCL 68 49 63 125
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 50 63 88
LOSARTAN-HYDROCHLOROTHIAZIDE 68 68 63 33
HYDRALAZINE HCL 68 68 63 54
PREDNISONE 67 66 67 40
MECLIZINE HCL 65 65 68 83
VALPROIC ACID 64 48 69 306
LANTUS 62 62 70 71
LEXAPRO 60 53 71 219
AMIODARONE HCL 59 59 72 139
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 46 73 26
EXELON 57 57 74 132
CLOTRIMAZOLE-BETAMETHASONE 57 56 74 166
ENABLEX 57 45 74 260
CARBIDOPA-LEVODOPA 56 56 77 124
METHOCARBAMOL 53 38 R 78 84
BUMETANIDE 52 51 79 96
HYDROXYZINE HCL 51 51 R 80 155
NITROFURANTOIN 50 50 81 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.